Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PediaCare Medicated Freezer Pops is an over-the-counter cough suppressant specifically formulated for children. Developed by Pfizer Consumer Healthcare, the product contains dextromethorphan as its active ingredient. Dextromethorphan is a small molecule that acts on the cough center in the medulla oblongata, decreasing the urge to cough by elevating the cough threshold. The product is unique for its delivery format, as it is sold as a liquid that can be frozen into freezer pops or consumed in its liquid state. It is indicated for the temporary relief of coughs due to the common cold or inhaled irritants, providing non-drowsy relief for up to eight hours. The formulation is alcohol-free and contains no fever reducers.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PediaCare Medicated Freezer Pops.